Sue S. Yom, MD, PhD
Associate Professor, Department of Radiation Oncology, UCSF
Cancer Center Program Memberships
Experimental TherapeuticsResearch Summary
My primary clinical and research interests include head and neck, thoracic, and cutaneous malignancies, where I have developed and led multiple clinical trials, both within UCSF and across sites nationwide and overseas. I am interested in the development and evaluation of new therapeutic techniques, which to me include novel molecular targeted agents and immunotherapies as well as state-of-the-art technical advances in radiation therapy. I have special interests in virally driven malignancies associated with humanpapillomavirus (HPV), Epstein-Barr virus (EBV), and Merkel cell polyomavirus. My research has entailed collaborating with laboratory-based investigators to identify patient, tumor, and technical characteristics that influence prognosis and response to specific therapies, including tissue-, blood-, and imaging-based biomarkers. Other university responsibilities include co-leading the site committees for clinical trial development in cutaneous and head and neck cancers at the UCSF HDFCCC and serving on the Cancer Committee which maintains our accreditation through the American College of Surgeons. Nationally, I have served as the chair of the scientific program and nominating committees for the American Radium Society (ARS), chair of the Appropriateness Committee guidelines for radiation oncology at the American College of Radiology (ACR), and head and neck senior editor at the International Journal for Radiation Oncology Biology Physics (IJROBP). I have been on the scientific program committees of the American Society for Radiation Oncology (ASTRO), the International Association for the Study of Lung Cancer (IASLC), and the American Head and Neck Society (AHNS). I am a member of the NRG Oncology Head and Neck Steering Committee, NCI’s Head and Neck Recurrent/Metastatic Disease Task Force, and the NCCN Head and Neck Cancers guidelines committee. I am a national boards examiner for the American Board of Radiology.Education
2002, University of Pennsylvania, Philadelphia, PA, M.D., Ph.D., Medicine/English
2003, U. T. – M. D. Anderson Cancer Center, Internship, Medicine/Surgery
2007, U. T. – M. D. Anderson Cancer Center, Residency, Radiation Oncology
Professional Experience
-
2007-2013
Assistant Professor of Clinical Radiation Oncology, University of California, San Francisco -
2007-present
Consultant in Radiology, San Francisco Veterans Administration Medical Center -
2008-2013
Assistant Professor in Otolaryngology-Head and Neck Surgery, by courtesy -
2013-present
Associate Professor of Clinical Radiation Oncology, University of California, San Francisco -
2013-present
Associate Professor in Otolaryngology-Head and Neck Surgery, by courtesy
Honors & Awards
- 1992
Mellon Fellow in the Humanities, Andrew W. Mellon Foundation - 1995
Benjamin Franklin Medical Scholar Fellowship, University of Pennsylvania - 2004
Thomas Barkley Award, M. D. Anderson Cancer Center - 2005
Fellowship, Korean American Society for Therapeutic Radiology & Oncology - 2006
Jesse H. Jones Fellowship in Cancer Education, M. D. Anderson Cancer Center - 2006
Outstanding Resident Presentation Award, Texas Radiological Society - 2006
A. Lavoy Moore Endowment Fund, M. D. Anderson Cancer Center - 2006
Eleanor Montague Distinguished Resident Award, American Association of Women Radiologists - 2008
Joan F. Giambalvo Memorial Scholarship, AMA Women Physicians Congress - 2009
Best Doctors in America, 2009-2014 - 2011
Educator of the Year Award, Association of Residents in Radiation Oncology
Selected Publications
- Yuan JT, Tello TL, Hultman C, Barker CA, Arron ST, Yom SS. Medical marijuana for the treatment of vismodegib-related muscle spasm. JAAD Case Rep. 2017 Sep; 3(5):438-440.
View on PubMed - Zietman AL, Yom SS. The Red Journal's Outstanding Reviewer Awards for 2016. Int J Radiat Oncol Biol Phys. 2017 Sep 01; 99(1):1-2.
View on PubMed - Fakhry C, Zhang Q, Nguyen-Tân PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SSD, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT, Gillison ML. Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer. J Clin Oncol. 2017 Aug 04; JCO2016720748.
View on PubMed - Koyfman SA, Yom SS. Clinical Research Ethics: Considerations for the Radiation Oncologist. Int J Radiat Oncol Biol Phys. 2017 Oct 01; 99(2):259-264.
View on PubMed - Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Lydiatt WM, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD. NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017. J Natl Compr Canc Netw. 2017 Jun; 15(6):761-770.
View on PubMed - Yom SS, Mallen-St Clair J, Ha PK. Controversies in Postoperative Irradiation of Oropharyngeal Cancer After Transoral Surgery. Surg Oncol Clin N Am. 2017 Jul; 26(3):357-370.
View on PubMed - Kim KY, Le QT, Yom SS, Pinsky BA, Bratman SV, Ng RH, El Mubarak HS, Chan KC, Sander M, Conley BA. Current State of PCR-Based Epstein-Barr Virus DNA Testing for Nasopharyngeal Cancer. J Natl Cancer Inst. 2017 04 01; 109(4).
View on PubMed - Ghosh P, Lazar AA, Ryan WR, Yom SS. A feasibility and efficacy trial of a hand-held humidification device in patients undergoing radiotherapy for head and neck cancer. Support Care Cancer. 2017 Aug; 25(8):2611-2618.
View on PubMed - Kim KY, Le QT, Yom SS, Ng RHW, Chan KCA, Bratman SV, Welch JJ, Divi RL, Petryshyn RA, Conley BA. Clinical Utility of Epstein-Barr Virus DNA Testing in the Treatment of Nasopharyngeal Carcinoma Patients. Int J Radiat Oncol Biol Phys. 2017 Aug 01; 98(5):996-1001.
View on PubMed - Yom SS. A Larynx Best Preserved, but by Radiation or Formalin? Int J Radiat Oncol Biol Phys. 2017 Apr 01; 97(5):889-890.
View on PubMed - Chapman CH, Parvathaneni U, Yom SS. Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part II: nasopharyngeal carcinoma. Future Oncol. 2017 Mar; 13(7):581-584.
View on PubMed - Chapman CH, Parvathaneni U, Yom SS. Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part I: carcinoma of non-nasopharyngeal sites. Future Oncol. 2017 Mar; 13(6):469-475.
View on PubMed - Boreta L, Yom SS. Is there a benefit to locally consolidative therapy for oligometastatic non-small cell lung cancer? Ann Transl Med. 2017 Mar; 5(5):108.
View on PubMed - Manyam BV, Garsa AA, Chin RI, Reddy CA, Gastman B, Thorstad W, Yom SS, Nussenbaum B, Wang SJ, Vidimos AT, Koyfman SA. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck. Cancer. 2017 Jun 01; 123(11):2054-2060.
View on PubMed - Paulsson AK, Yom SS, Anwar M, Pinnaduwage D, Sudhyadhom A, Gottschalk AR, Chang AJ, Descovich M. Respiration-Induced Intraorgan Deformation of the Liver. Technol Cancer Res Treat. 2017 Jan 01; 1533034616687193.
View on PubMed - Kim H, Chen J, Phillips J, Pukala J, Yom SS, Kirby N. Validating Dose Uncertainty Estimates Produced by AUTODIRECT: An Automated Program to Evaluate Deformable Image Registration Accuracy. Technol Cancer Res Treat. 2017 Jan 01; 1533034617708076.
View on PubMed - Palma DA, Yom SS, Bennett KE, Corry J, Zietman AL. Introducing: The Red Journal Gray Zone. Int J Radiat Oncol Biol Phys. 2017 Jan 01; 97(1):1.
View on PubMed - Yom SS. The Tonsillar Fossa Battleground. Int J Radiat Oncol Biol Phys. 2017 Jan 01; 97(1):1-2.
View on PubMed - Siddiqui F, Smith RV, Yom SS, Beitler JJ, Busse PM, Cooper JS, Hanna EY, Jones CU, Koyfman SA, Quon H, Ridge JA, Saba NF, Worden F, Yao M, Salama JK. ACR appropriateness criteria® nasal cavity and paranasal sinus cancers. Head Neck. 2017 Mar; 39(3):407-418.
View on PubMed - Yom SS. Is Induction Chemotherapy Needed to Select Patients for Deintensified Treatment of Human Papillomavirus-Associated Oropharyngeal Cancer? J Clin Oncol. 2016 Dec 28; JCO2016710681.
View on PubMed